Department of Neurosurgery, Hainan Province People's Hospital, Haikou 570311, China.
Neurosci Bull. 2008 Feb;24(1):34-8. doi: 10.1007/s12264-008-1029-y.
To investigate the expressions of Galectin-3 (Gal-3), Bcl-2 and Bax in human pituitary adenomas, and to explore the interrelation among them.
RT-PCR and immunohistochemistry were applied to detect the mRNA and protein expressions of Gal-3, Bcl-2 and Bax in surgically excised human pituitary adenoma tissues, including invasive and non-invasive pituitary adenomas, and the correlation analysis was performed.
The Gal-3 and Bcl-2 expressions in the invasive pituitary group were significantly higher than those in the non-invasive group, and the expression of Bax had no significant difference between the two groups. Pearsonos correlation analyses showed that the Gal-3 expression was positively correlated with Bcl-2, but was not correlated with Bax, which was inversely correlated with expression of Bcl-2.
Gal-3 may function through a cell death inhibition pathway involving Bcl-2 to enhance cell proliferation, which result in the invasive growth of pituitary adenoma. These results indicate that Gal-3 has an important role in pituitary tumor cell proliferation and may serves as a possible therapeutic target in treatment of pituitary tumors.
研究半乳糖凝集素-3(Gal-3)、Bcl-2 和 Bax 在人垂体腺瘤中的表达,并探讨它们之间的相互关系。
应用 RT-PCR 和免疫组织化学方法检测手术切除的人垂体腺瘤组织中 Gal-3、Bcl-2 和 Bax 的 mRNA 和蛋白表达,包括侵袭性和非侵袭性垂体腺瘤,并进行相关性分析。
侵袭性垂体组 Gal-3 和 Bcl-2 的表达明显高于非侵袭性组,两组 Bax 的表达无明显差异。Pearson 相关分析表明,Gal-3 的表达与 Bcl-2 呈正相关,与 Bax 不相关,而与 Bcl-2 的表达呈负相关。
Gal-3 可能通过涉及 Bcl-2 的细胞死亡抑制途径发挥作用,从而增强细胞增殖,导致垂体腺瘤的侵袭性生长。这些结果表明,Gal-3 在垂体瘤细胞增殖中具有重要作用,可能成为治疗垂体瘤的潜在治疗靶点。